JLABS logo

JLABS

North America, California, United States, San Diego

Description

JLABS is a life science network providing startups with access to capital-efficient lab space and resources.

Investor Profile

JLABS has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Series Unknown (25%)
  • Non Equity Assistance (25%)
  • Series B (13%)
  • Series A (13%)
  • Seed (13%)
  • Series C (13%)

Country Focus

  • United States (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
  • Bioinformatics
  • Genetics
  • Oncology
  • Pharmaceutical
  • Machinery Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does JLABS frequently co-invest with?

QB3
North America, California, United States, San Francisco
Co-Investments: 2
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Foothill Ventures
North America, California, United States, Los Altos
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Fusion Fund
North America, California, United States, Palo Alto
Co-Investments: 1
Chan Zuckerberg Initiative
North America, California, United States, Palo Alto
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 3
Cota Capital
North America, California, United States, San Francisco
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 3

Which angels does JLABS often collaborate with?

SH
North America, North Carolina, United States, Raleigh
Shared Deals: 1
JF
North America, California, United States
Shared Deals: 1

What are some of recent deals done by JLABS?

Vincere Biosciences

Cambridge, Massachusetts, United States

Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).

Biotechnology
SeedNov 25, 2020
Amount Raised: $1,750,000
Antiva Biosciences

Del Mar, California, United States

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

BiotechnologyHealth CareMedical
Series CJul 10, 2018
Amount Raised: $15,000,000
Mission Bio

San Francisco, California, United States

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

BioinformaticsBiotechnologyGeneticsHealth CareOncology
Series UnknownJun 29, 2018
Iconic Therapeutics

South San Francisco, California, United States

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

BiopharmaBiotechnologyTherapeutics
Series UnknownJun 15, 2018
Amount Raised: $4,110,000
Pionyr Immunotherapeutics

South San Francisco, California, United States

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BDec 13, 2017
Amount Raised: $62,000,000
Compass Therapeutics, Inc.

Boston, Massachusetts, United States

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

BiopharmaBiotechnologyTherapeutics
Series AJul 11, 2017
Qing Bile Therapeutics

Vancouver, British Columbia, Canada

Qing Bile Therapeutics is a biotechnology company that treats cholestatic and metabolic diseases using a type of bile acid they identified.

BiotechnologyHealth CareMedical
Non Equity AssistanceMay 11, 2016
PinPress

Port Hope, Ontario, Canada

PinPress is a one-size-fits-all mould designed to save manufacturers time and money.

Machinery ManufacturingManufacturingMechanical DesignMechanical Engineering
Non Equity AssistanceMay 11, 2016